Donate
Members
About Us
About ANZCHOG
Board of Directors
Our People
Our Members
Supporters & Partners
The Challenges of Childhood Cancer
Clinical Trials & Research
Clinical Trials
Clinical Trial Support
Research
ANZCHOG Biobanking Network
ANZCHOG Children’s Cancer Clinical Trials Repository
Collaborations
Brain Cancer Mission
Background
Trials Advisory Group
Clinical Trials Supported
ASM
News
Events
Contact Us
Australian & New Zealand Childrens Haematology/Oncology Group
Donate
Members
About Us
About ANZCHOG
Board of Directors
Our People
Our Members
Supporters & Partners
The Challenges of Childhood Cancer
Clinical Trials & Research
Clinical Trials
Clinical Trial Support
Research
ANZCHOG Biobanking Network
ANZCHOG Children’s Cancer Clinical Trials Repository
Collaborations
Brain Cancer Mission
Background
Trials Advisory Group
Clinical Trials Supported
ASM
News
Events
Contact Us
Clinical Trials
Home
Clinical Trials & Research
Clinical Trials
Viewing: Clinical Trials
Filter by
Closed to Recruitment
Preparing to Open
Open
In Development
Craniopharyngioma
Status:
Preparing to Open
PNOC029: Nivolumab and DAY101 for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults
Read more
Adamantinomatous Craniopharyngioma
Status:
In Development
CONNECT2108: Phase 2 Study of the MEK inhibitor MEKTOVI® (binimetinib) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma
Read more
Medulloblastoma
Status:
In Development
SJiMB21: Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children with Newly Diagnosed Medulloblastoma
Read more
Acute Lymphoblastic Leukemia
Status:
Preparing to Open
RAVEN: A phase I/II trial treating relapsed acute lymphoblastic leukemia with venetoclax and navitoclax
Read more
Adamantinomatous Craniopharyngioma
Status:
Open
|
WA
CONNECT1905: Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (tocilizumab) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma
Read more
Medulloblastoma
Status:
Open
|
NSW , VIC
MetMED: Phase III randomized double-blind placebo-controlled trial of metformin for white matter repair and cognitive recovery in paediatric brain tumour patients
Read more
First
Previous
1
2
3
Next
Last
All posts loaded.
All posts loaded.
Load more trials